Cargando…

Effectiveness of Valsartan’s Single-Pill Combination Therapies on Blood Pressure Control in Hypertensive Patients: Malaysian Single-Centre Real-World Experience

BACKGROUND: Uncontrolled hypertension can cause cardiovascular disease and is an important public health issue. Single-pill combination (SPC) therapies possess combined blood pressure (BP)-lowering effect and may improve compliance to treatment. This study assessed the effectiveness of valsartan (Va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yusof, Ahmad K. M., Halil, Norhazreen Mohamad, Jaffar, Norfazlina, Sabian, Intan Safarinaz, Looi, Zhi Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Penerbit Universiti Sains Malaysia 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624431/ https://www.ncbi.nlm.nih.gov/pubmed/37928782 http://dx.doi.org/10.21315/mjms2023.30.5.10

Ejemplares similares

Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017)

Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertension
por: Mende, Christian W., et al.
Publicado: (2017)

Real-life Effectiveness and Safety of Amlodipine/Valsartan Single-pill Combination in Patients with Hypertension in Egypt: Results from the EXCITE Study
por: Assaad-Khalil, Samir H., et al.
Publicado: (2016)

Efficacy and Safety of Valsartan/Amlodipine Single-Pill Combination in 11,422 Chinese Patients with Hypertension: an Observational Study
por: Hu, Dayi, et al.
Publicado: (2014)

Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational study
por: Hagendorff, Andreas, et al.
Publicado: (2014)

Effectiveness of Valsartan/Amlodipine Single-pill Combination in Hypertensive Patients With Excess Body Weight: Subanalysis of China Status II
por: Ge, Beihai, et al.
Publicado: (2015)

Gender difference in the response to valsartan/amlodipine single-pill combination in essential hypertension (China Status II): An observational study
por: Wang, Huan, et al.
Publicado: (2016)

Eligibility of sacubitril–valsartan in a real‐world heart failure population: a community‐based single‐centre study
por: Norberg, Helena, et al.
Publicado: (2018)

Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components
por: Stafylas, Panagiotis, et al.
Publicado: (2015)

Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors
por: Oh, Jaewon, et al.
Publicado: (2023)

Chart review of patients receiving valsartan–amlodipine single-pill combination versus valsartan and amlodipine combination for blood pressure goal achievement and effects on the Hamilton anxiety rating/Hamilton depression rating scales
por: Yin, Gang, et al.
Publicado: (2019)

Amlodipine/Valsartan (Avsar®): Efficacy in Hypertensive Patients - A Real World Observational Study (ALERT)
por: Khan, Khalid M, et al.
Publicado: (2020)

Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development
por: Paczkowska-Walendowska, Magdalena, et al.
Publicado: (2022)

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
por: Assaad-Khalil, Samir Helmy, et al.
Publicado: (2015)

Expanding role for single‐pill combination drug therapy in the initial treatment of hypertension?
por: Li, Yanglong, et al.
Publicado: (2021)

The Effects of Single Pill Combinations on Adherence and Blood Pressure Control in Hypertensive Patients
por: Naser, Nabil, et al.
Publicado: (2022)

Clinical effectiveness and safety of amlodipine/losartan‐based single‐pill combination therapy in patients with hypertension: Findings from real‐world, multicenter observational databases
por: Lee, Jieun, et al.
Publicado: (2021)

Sacubitril/Valsartan in Heart Failure Hospitalization: Two Pills a Day to Keep Hospitalizations Away?
por: Sakhamuri, Navya, et al.
Publicado: (2023)

Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy
por: Borghi, Claudio, et al.
Publicado: (2023)

Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program
por: Abraham, Ivo, et al.
Publicado: (2011)

Is it Time for Single-Pill Combinations in Dyslipidemia?
por: Schiele, François, et al.
Publicado: (2021)

Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)
por: Sohn, Il Suk, et al.
Publicado: (2021)

Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study
por: Wilke, Thomas, et al.
Publicado: (2022)

Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill
por: Burnier, Michel
Publicado: (2010)

Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension
por: Billecke, Scott S, et al.
Publicado: (2013)

Adherence and Health Care Costs with Single-Pill Fixed-Dose Combinations in Hypertension Management
por: Hilleman, Daniel E.
Publicado: (2014)

Estimating the impact of single pill combination therapy for hypertension: projections of patient outcomes in Italy
por: Borghi, Claudio, et al.
Publicado: (2023)

Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen
por: Patel, Bimal V, et al.
Publicado: (2008)

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Lipid lowering with inclisiran: a real-world single-centre experience
por: Padam, Pritpal, et al.
Publicado: (2022)

The history and mystery of sacubitril/valsartan: From clinical trial to the real world
por: Zhang, Mingsong, et al.
Publicado: (2023)

Is Time an Important Problem in Management of Hypertension and Hypercholesterolemia by Using an Amlodipine-Atorvastatin Single Pill Combination?
por: Zeng, Rui, et al.
Publicado: (2016)

Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform
por: Volpe, Massimo, et al.
Publicado: (2017)

EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
por: Naydenov Naydenov, Stefan, et al.
Publicado: (2018)

Projecting the long-term benefits of single pill combination therapy for patients with hypertension in five countries
por: Borghi, Claudio, et al.
Publicado: (2021)

Aliskiren and valsartan combination therapy for the management of hypertension
por: Epstein, Benjamin J
Publicado: (2010)

Sorafenib for the Treatment of Hepatocellular Carcinoma: A Single-centre Real-world Study
por: Hanzel, Jurij, et al.
Publicado: (2020)

Knowledge of acute stroke management and the predictors among Malaysian healthcare professionals
por: Albart, Stephenie Ann, et al.
Publicado: (2022)

Single‐pill combination of cilnidipine, an l‐/n‐type calcium channel blocker, and valsartan reduces the day‐by‐day variability of morning home systolic blood pressure in patients with treated hypertension: A sub‐analysis of the HOPE‐combi survey
por: Kario, Kazuomi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d6vootcru6m5pi5uc36ehdq409